Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Cold Storage Transfer of Heat-Sensitive Batches – V 2.0

Posted on By

Elixir Department: SOP for Cold Storage Transfer of Heat-Sensitive Batches – V 2.0

Standard Operating Procedure for Cold Storage Transfer of Heat-Sensitive Batches in Elixir Manufacturing

Department Elixir Department
SOP No. SOP/ELX/111/2025
Supersedes SOP/ELX/111/2022
Page No. Page 1 of 8
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To define the procedure for safe and controlled transfer of heat-sensitive elixir batches to cold storage facilities, maintaining product integrity and ensuring compliance with temperature requirements.

2. Scope

This SOP applies to all heat-sensitive bulk or intermediate elixir batches requiring cold storage transfer within the Elixir Department after manufacturing or before packaging.

3. Responsibilities

  • Production Operator:
    • Ensure proper sealing and labeling of containers before transfer.
    • Escort batch containers to the designated cold storage area.
  • Production Supervisor:
    • Verify temperature conditions and documentation before and after transfer.
  • QA Officer:
    • Ensure temperature compliance, review records, and approve batch storage.
See also  Elixir Department: SOP for In-Process Filter Integrity Testing - V 2.0

4. Accountability

The Head of Production is accountable for ensuring that all heat-sensitive batches are stored and transferred under controlled cold conditions with proper documentation.

5. Procedure

5.1 Identification of Heat-Sensitive

Batches
  1. Refer to the Master Formula Record (MFR) to confirm cold storage requirement (e.g., 2–8°C).
  2. Ensure batch containers are tightly closed and labeled with:
    • Batch Number
    • Product Name
    • Storage Condition (e.g., “Store at 2–8°C”)
    • Transfer Date and Time

5.2 Pre-Transfer Checks

  1. Confirm that the cold storage chamber is clean and within temperature range.
  2. Ensure that the cold storage area has a working temperature logger or chart recorder.
  3. Verify that the trolleys or containers used for transfer are sanitized and pre-cooled if necessary.

5.3 Transfer Procedure

  1. Initiate transfer immediately after batch processing or sampling.
  2. Minimize exposure time to ambient conditions by using shortest transfer route.
  3. Escort the containers to cold storage and place them in designated rack/area.
  4. Record temperature at the time of entry into cold storage using a calibrated thermometer.

5.4 Documentation and Monitoring

  1. Document transfer details in the Cold Storage Transfer Log (Annexure-1).
  2. Verify and document actual storage temperature using the monitoring device logs.
  3. QA to verify transfer log and confirm that product remains within allowed temperature range.

5.5 Deviation Handling

  1. If temperature exceeds defined limits during transfer, report deviation to QA immediately.
  2. Hold the batch under quarantine until impact assessment is completed.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • BMR: Batch Manufacturing Record
  • MFR: Master Formula Record

7. Documents

  1. Cold Storage Transfer Log (Annexure-1)
  2. Temperature Monitoring Records
  3. Batch Manufacturing Record (BMR)

8. References

  • WHO TRS 961 – Stability Testing and Cold Chain Management
  • 21 CFR Part 211.142 – Storage of Drug Products
  • Internal SOP on Deviation Management

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Cold Storage Transfer Log

Date Batch No. Product Name Time of Transfer Storage Temp (°C) Transferred By QA Verified
11/04/2025 ELX-1047 Elixir A 14:30 4.5 Rajesh Kumar Sunita Reddy

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial SOP Release New SOP QA Head
11/04/2025 2.0 Added deviation handling and labeling steps Cold Chain Compliance QA Head
Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

Post navigation

Previous Post: Analytical Method Development: Identification of Process Related Impurities – V 2.0
Next Post: Aerosol: SOP for Preventing Mix-Ups During Material Handling – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version